Finance

Beta
Lists
300957:SHE
Yunnan Botanee Bio-Tech Grp Co Ltd
CN¥34.43
+0.70%
(+0.24) 1D
Jun 5, 3:04:16 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300957...
Open
CN¥34.39
High
CN¥35.37
Low
CN¥34.21
Mkt. cap
14.58B
Avg. vol.
7.53M
Volume
6.04M
Dividend
1.89%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 28, 2026
P/E ratio
27.28
52-wk high
CN¥51.80
52-wk low
CN¥33.90
EPS
CN¥1.26
Shares outstanding
423.60M
No. of employees
4K
Open
CN¥34.39
High
CN¥35.37
Low
CN¥34.21
Mkt. cap
14.58B
Avg. vol.
7.53M
Volume
6.04M
Dividend
1.89%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 28, 2026
P/E ratio
27.28
52-wk high
CN¥51.80
52-wk low
CN¥33.90
EPS
CN¥1.26
Shares outstanding
423.60M
No. of employees
4K
News stories
From sources across the web
About Yunnan Botanee Bio-Tech Grp Co Ltd
CEO-
Employees3.57K
FoundedMay 13, 2010
Headquarters-
SectorPersonal care products
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.42B
1.09B
1.89B
1.12B
Cost of goods sold
331.43M
344.15M
514.35M
297.98M
Cost of revenue
331.43M
344.15M
514.35M
297.98M
Research and development expenses
58.52M
55.00M
65.94M
34.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
827.48M
688.15M
1.01B
698.92M
Operating expense
900.91M
761.04M
1.10B
737.47M
Total operating expenses
1.23B
1.11B
1.62B
1.04B
Operating income
190.74M
-12.75M
276.55M
82.58M
Other non operating income
604.77K
-5.75M
4.77M
-2.47M
EBT including unusual items
254.02M
36.65M
283.19M
106.32M
EBT excluding unusual items
226.58M
14.72M
285.07M
83.23M
Income tax expense
36.80M
9.13M
42.32M
44.27M
Effective tax rate
14.49%
24.92%
14.94%
41.64%
Other operating expenses
16.79M
9.62M
40.54M
7.93M
Net income
218.32M
25.22M
233.84M
65.97M
Net profit margin
15.34%
2.31%
12.34%
5.90%
Earnings per share
-
-
-
-
Interest and investment income
43.26M
33.18M
13.03M
8.07M
Interest expense
-7.98M
-
-7.19M
-4.95M
Net interest expenses
35.28M
33.18M
5.84M
3.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
215.56M
11.07M
303.96M
109.98M
Gain or loss from assets sale
-2.71M
2.71M
-2.57M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more